Joseph W. Reda

This paper develops a nanotherapy to reprogram antigen-presenting cells and induce T cell anergy, delaying type 1 diabetes onset in mice.

This study shows that albumin-fused IL-10 reduces experimental autoimmune encephalomyelitis by enhancing immunoregulation in secondary lymphoid organs.

This paper develops a targeted IL-10 therapy by fusing it with an LDL-binding antibody fragment, showing reduced vascular inflammation in atherosclerotic mice.